WO2002012459A2 - Verfahren zur verbesserten herstellung von cyanophycin und dessen folgeprodukte - Google Patents
Verfahren zur verbesserten herstellung von cyanophycin und dessen folgeprodukte Download PDFInfo
- Publication number
- WO2002012459A2 WO2002012459A2 PCT/EP2001/008690 EP0108690W WO0212459A2 WO 2002012459 A2 WO2002012459 A2 WO 2002012459A2 EP 0108690 W EP0108690 W EP 0108690W WO 0212459 A2 WO0212459 A2 WO 0212459A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cyanophycin
- synthetase
- cyanophycin synthetase
- asp
- nucleotide sequence
- Prior art date
Links
- QCGCETFHYOEVAI-GDVGLLTNSA-N (2s)-2-[(3-amino-3-carboxypropanoyl)amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound OC(=O)C(N)CC(=O)N[C@H](C(O)=O)CCCN=C(N)N QCGCETFHYOEVAI-GDVGLLTNSA-N 0.000 title claims abstract description 36
- 108010031546 cyanophycin Proteins 0.000 title claims abstract description 36
- 229920000976 cyanophycin polymer Polymers 0.000 title claims abstract description 36
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 21
- 238000000034 method Methods 0.000 title claims abstract description 20
- 101710192124 Cyanophycin synthetase Proteins 0.000 claims abstract description 52
- 241001453296 Synechococcus elongatus Species 0.000 claims abstract description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 29
- 125000003729 nucleotide group Chemical group 0.000 claims description 26
- 239000002773 nucleotide Substances 0.000 claims description 25
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 18
- 102000004169 proteins and genes Human genes 0.000 claims description 14
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 108090000790 Enzymes Proteins 0.000 claims description 13
- 230000015572 biosynthetic process Effects 0.000 claims description 13
- 238000003786 synthesis reaction Methods 0.000 claims description 13
- 239000013598 vector Substances 0.000 claims description 13
- 150000001413 amino acids Chemical group 0.000 claims description 11
- 239000004475 Arginine Substances 0.000 claims description 8
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 230000001105 regulatory effect Effects 0.000 claims description 8
- 150000007523 nucleic acids Chemical group 0.000 claims description 6
- 239000000523 sample Substances 0.000 claims description 6
- 241000196324 Embryophyta Species 0.000 claims description 5
- 108010044467 Isoenzymes Proteins 0.000 claims description 5
- 108700028369 Alleles Proteins 0.000 claims description 4
- 241000233866 Fungi Species 0.000 claims description 4
- 229920000805 Polyaspartic acid Polymers 0.000 claims description 4
- 230000014509 gene expression Effects 0.000 claims description 4
- 244000005700 microbiome Species 0.000 claims description 4
- 108010064470 polyaspartate Proteins 0.000 claims description 4
- 238000012986 modification Methods 0.000 claims description 3
- 230000004048 modification Effects 0.000 claims description 3
- 238000013519 translation Methods 0.000 claims description 3
- 238000001514 detection method Methods 0.000 claims description 2
- 238000002955 isolation Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 238000013518 transcription Methods 0.000 claims description 2
- 230000035897 transcription Effects 0.000 claims description 2
- 238000011144 upstream manufacturing Methods 0.000 claims description 2
- QCGCETFHYOEVAI-WDSKDSINSA-N beta-Asp-Arg Chemical compound OC(=O)[C@@H](N)CC(=O)N[C@H](C(O)=O)CCCNC(N)=N QCGCETFHYOEVAI-WDSKDSINSA-N 0.000 description 28
- 108090000765 processed proteins & peptides Proteins 0.000 description 23
- 239000000047 product Substances 0.000 description 17
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 14
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 14
- 235000018102 proteins Nutrition 0.000 description 11
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 9
- 108020004414 DNA Proteins 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- 229920005989 resin Polymers 0.000 description 8
- 239000011347 resin Substances 0.000 description 8
- 238000013459 approach Methods 0.000 description 7
- 235000009697 arginine Nutrition 0.000 description 7
- 229960003121 arginine Drugs 0.000 description 7
- 229960005261 aspartic acid Drugs 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 229940024606 amino acid Drugs 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- 108091026890 Coding region Proteins 0.000 description 4
- -1 O- (benzotriazol-l-yl) - N, N, N ', N'-tetramethyluronium tetrafluoroborate Chemical compound 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 235000003704 aspartic acid Nutrition 0.000 description 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 4
- 210000004899 c-terminal region Anatomy 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 3
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 3
- 229930064664 L-arginine Natural products 0.000 description 3
- 235000014852 L-arginine Nutrition 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 238000004949 mass spectrometry Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 238000003752 polymerase chain reaction Methods 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- QTWZCODKTSUZJN-LJAQVGFWSA-N (2s)-5-[[amino-[(2,2,5,7,8-pentamethyl-3,4-dihydrochromen-6-yl)sulfonylamino]methylidene]amino]-2-(9h-fluoren-9-ylmethoxycarbonylamino)pentanoic acid Chemical compound C12=CC=CC=C2C2=CC=CC=C2C1COC(=O)N[C@H](C(O)=O)CCCN=C(N)NS(=O)(=O)C(C(C)=C1C)=C(C)C2=C1OC(C)(C)CC2 QTWZCODKTSUZJN-LJAQVGFWSA-N 0.000 description 2
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 2
- 241000192698 Aphanocapsa Species 0.000 description 2
- 108700010070 Codon Usage Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methylaniline Chemical compound CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 241000192593 Synechocystis sp. PCC 6803 Species 0.000 description 2
- TTWYZDPBDWHJOR-IDIVVRGQSA-L adenosine triphosphate disodium Chemical compound [Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O TTWYZDPBDWHJOR-IDIVVRGQSA-L 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 238000001906 matrix-assisted laser desorption--ionisation mass spectrometry Methods 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- 238000004886 process control Methods 0.000 description 2
- 238000004007 reversed phase HPLC Methods 0.000 description 2
- GEUFMGZEFYJAEJ-UHFFFAOYSA-N tris(2-methylpropyl)silicon Chemical compound CC(C)C[Si](CC(C)C)CC(C)C GEUFMGZEFYJAEJ-UHFFFAOYSA-N 0.000 description 2
- KSDTXRUIZMTBNV-INIZCTEOSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)butanedioic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](CC(=O)O)C(O)=O)C3=CC=CC=C3C2=C1 KSDTXRUIZMTBNV-INIZCTEOSA-N 0.000 description 1
- VZXQYACYLGRQJU-IBGZPJMESA-N (3s)-3-(9h-fluoren-9-ylmethoxycarbonylamino)-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](CC(O)=O)C(=O)OC(C)(C)C)C3=CC=CC=C3C2=C1 VZXQYACYLGRQJU-IBGZPJMESA-N 0.000 description 1
- RAUQRYTYJIYLTF-QMMMGPOBSA-N (3s)-4-[(2-methylpropan-2-yl)oxy]-3-[(2-methylpropan-2-yl)oxycarbonylamino]-4-oxobutanoic acid Chemical compound CC(C)(C)OC(=O)N[C@@H](CC(O)=O)C(=O)OC(C)(C)C RAUQRYTYJIYLTF-QMMMGPOBSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 238000012369 In process control Methods 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000192560 Synechococcus sp. Species 0.000 description 1
- 241000078013 Trichormus variabilis Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000004566 building material Substances 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000012411 cloning technique Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 238000010965 in-process control Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940124280 l-arginine Drugs 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000010327 methods by industry Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000000302 molecular modelling Methods 0.000 description 1
- CMWYAOXYQATXSI-UHFFFAOYSA-N n,n-dimethylformamide;piperidine Chemical compound CN(C)C=O.C1CCNCC1 CMWYAOXYQATXSI-UHFFFAOYSA-N 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- RYYVRFAJTNFQBC-SFHVURJKSA-N tert-butyl (2s)-2-amino-5-[[amino-[(2,2,5,7,8-pentamethyl-3,4-dihydrochromen-6-yl)sulfonylamino]methylidene]amino]pentanoate Chemical compound C1CC(C)(C)OC2=C1C(C)=C(S(=O)(=O)NC(=N)NCCC[C@H](N)C(=O)OC(C)(C)C)C(C)=C2C RYYVRFAJTNFQBC-SFHVURJKSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 244000045561 useful plants Species 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Definitions
- the present invention relates to a thermostable cyanophycin synthase, transformed organisms containing such an enzyme, and a method for the improved production of cyanophycin and / or its secondary products, for example polyaspartic acid or arginine.
- Multi-L-Arginyl-Poly-L-aspartate is a branched polypeptide that contains aspartic acid and arginine in a ratio of 1: 1.
- Structure corresponds to a poly- ⁇ -aspartate backbone with arginine side residues, which are linked to almost all ⁇ -carboxyl groups of the backbone via peptide bonds.
- DE-A 197 09 024 discloses the extraction and purification of cyanophycin from Aphanocapsa PCC 6308, the synthesis being carried out at 20 ° C.
- FEMS Microbiology Letters 181 (1999) 229-236 describes the production of cyanophycin from Synechococcus sp. MA 19 known.
- a disadvantage of the large-scale production of cyanophycin according to the known processes is that a relatively narrow temperature range, generally below 35 ° C., must not be exceeded for optimum product yield.
- the present invention relates to a cyanophycin synthetase which is characterized in that it codes a temperature optimum in the range of> 35 ° C. and an amino acid sequence according to SEQUENCE PROTOCOL 1 by an isolated nucleotide sequence according to SEQUENCE PROTOCOL 2, an allele, homologue or derivative of this nucleotide sequence or with this has a hybridizing nucleotide sequence.
- the cyanophycin synthetase according to the invention has an optimum temperature in the range from 35 ° C. to 55 ° C., preferably in the range from 35 to 50 ° C.
- the cyanophycin synthetase according to the invention is distinguished by the fact that it originates from Synechococcus elongatus.
- the cyanophycin syn- thetase is a thermostable enzyme.
- the present invention also relates to isoenzymes of the cyanophycin synthetase according to the invention.
- This includes enzymes with the same or comparable substrate and activity specificity, but which have a different primary structure.
- the present invention also includes modified forms of cyanophycin synthetase. According to the invention, this includes enzymes in which there are changes in the sequence, for example at the N- and / or C-terminus of the polypeptide or in the region of conserved amino acids, but without impairing the function of the enzyme. These changes can be made by exchanging one or more amino acids according to known methods.
- a special embodiment variant of the present invention comprises variants of the cyanophycin synthetase according to the invention, the substrate specificity of which has been changed, for example, by amino acid exchange compared with the respective starting protein, for example with regard to the production of polyaspartic acid.
- the present invention furthermore relates to polypeptides with the function of a cyanophycin synthetase, the amino acid sequence of which is changed in such a way that they are desensitive to regulatory compounds, for example the end products of metabolism regulating their activity (feedback-desensitive).
- an isolated nucleotide sequence or an isolated nucleic acid fragment is to be understood as a polymer made from RNA or DNA, which can be single or double-stranded and optionally contain natural, chemically synthesized, modified or artificial nucleotides.
- DNA polymer also includes genomic DNA, cDNA or mixtures thereof.
- alleles are to be understood as functionally equivalent, ie essentially equivalent nucleotide sequences. Functionally equivalent sequences are those sequences which, despite a different nucleotide sequence, for example due to the degeneracy of the genetic code, still have the desired functions.
- Functional equivalents thus include naturally occurring variants of the sequences described here as well as artificial nucleotide sequences, for example those obtained by chemical synthesis and possibly adapted to the codon use of the host organism.
- functionally equivalent sequences include those which have an altered nucleotide sequence which corresponds to the
- Enzyme for example, gives a desensitivity or resistance to inhibitors.
- a functional equivalent is also understood to mean, in particular, natural or artificial mutations in an originally isolated sequence which continues to show the desired function. Mutations include substitutions, additions,
- nucleotide residues Deletions, exchanges or insertions of one or more nucleotide residues. Also included here are so-called sense mutations, which can lead to the exchange of conserved amino acids at the protein level, but which do not lead to a fundamental change in the activity of the protein and are therefore function-neutral. This also includes changes in the nucleotide sequence that affect the N- or C-terminus of a protein at the protein level, but without significantly impairing the function of the protein. These changes can even have a stabilizing influence on the protein structure.
- the present invention also encompasses, for example, those nucleotide sequences which are obtained by modifying the nucleotide sequence, resulting in corresponding derivatives.
- the aim of such a modification can, for example, be to further narrow down the coding sequence contained therein or, for example, also to insert further recognition sites for restriction enzymes.
- Functional equivalents are also those variants whose function is weakened or enhanced compared to the original gene or gene fragment.
- artificial DNA sequences are the subject of the present invention as long as they impart the desired properties as described above and can be incorporated or appended into the gene of the cyanophycin synthetase according to the invention.
- Such artificial DNA sequences can be determined, for example, by back-translating proteins created using computer-aided programs (molecular modeling) or by in-vitro selection. Coding DNA sequences which are obtained by back-translating a polypeptide sequence according to the codon usage specific for the host organism are particularly suitable. The specific codon usage can easily be determined by a person familiar with molecular genetic methods by computer evaluations of other, already known genes of the organism to be transformed.
- homologous sequences are to be understood as those which are complementary to and / or hybridize with the nucleotide sequences according to the invention.
- hybridizing sequences includes substantially similar nucleotide sequences from the group of DNA or RNA which, under known stringent conditions, enter into a specific interaction (binding) with the aforementioned nucleotide sequences. This also includes short nucleotide sequences with a length of, for example, 10 to 30, preferably
- nucleotide primers or probes 12 to 15 nucleotides. According to the invention, this includes also so-called nucleotide primers or probes.
- the preceding (5'- or upstream) and / or subsequent (3'- or downstream) coding regions are also also present.
- regulatory sequences include promoters, enhancers, operators, terminators or translation enhancers.
- An operative link is understood to mean the sequential arrangement of, for example, the promoter, coding sequence, terminator and, if appropriate, further regulatory elements in such a way that each of the regulatory elements can fulfill its function as intended when expressing the coding sequence.
- These regulatory nucleotide sequences can be of natural origin or can be obtained by chemical synthesis. In principle, any promoter which can control gene expression in the corresponding host organism is suitable as the promoter.
- this can also be a chemically inducible promoter by means of which the expression of the genes underlying it in the host cell can be controlled at a specific point in time.
- a promoter that can be induced by IPTG (isopropyl- ⁇ -thiogalactoside) is mentioned here as an example.
- a gene structure is produced by fusing a suitable promoter with the nucleotide sequence according to the invention using common recombination and cloning techniques as are known from the literature.
- DNA fragments with one another can be attached to the fragments adapters or linkers.
- the present invention relates to a vector comprising at least one nucleotide sequence of the type described above coding for a cyanophycin synthetase specific for the production of cyanophycin, to regulative nucleotide sequences operatively linked thereto and to additional nucleotide sequences for selecting transformed host cells, for replication within the host cell or for Integration into the corresponding host cell genome.
- the vector according to the invention can contain a gene structure of the aforementioned type.
- Suitable vectors are those which are replicated in microorganisms, such as bacteria, fungi and / or plants.
- Known vectors are, for example, pBluescript (Stratagene, 11099 North Torney Pines Rd., La Jolla, CA 92 037, USA) or pET (Novagen, 601 Science Drive, Madison, WJ 53 711, USA).
- pBluescript Stratagene, 11099 North Torney Pines Rd., La Jolla, CA 92 037, USA
- pET Novagen, 601 Science Drive, Madison, WJ 53 711, USA.
- this list is not limiting for the present invention.
- corresponding probes or nucleotide primers can be synthesized and used to amplify and isolate analog genes from other single or multicellular organisms, preferably bacteria, fungi, algae or plants, for example with the aid of PCR technology.
- the present invention thus also relates to a probe for identifying and / or isolating genes coding for proteins involved in the biosynthesis of cyanophycin, preferably further thermostable cyanophycin synthetases, this probe being produced on the basis of the nucleic acid sequences of the type described above and one for detection contains suitable marking.
- the probe can be a partial section of the sequence according to the invention, for example from a conserved area, which e.g. has a length of 10 to 30 or preferably 12 to 15 nucleotides and can hybridize specifically with homologous nucleotide sequences under stringent conditions. Suitable markings are well known from the literature.
- the present invention further relates to the transfer of the nucleic acid sequence according to the invention or a part thereof coding for a cyanophycin synthetase, an allele, homolog or derivative thereof or a nucleotide sequence hybridizing with these sequences into a heterologous host system.
- This also includes the transfer of a gene construct or vector according to the invention into a heterologous host system.
- a heterologous host system is understood to mean a single-cell or multi-cell organism. Examples of these are microorganisms, fungi, lower or higher plants, tissues or cells thereof. Bacteria are preferred according to the invention, particularly preferred the genus of enterobacteria and in particular the type Escherichia coli. Furthermore, useful plants, such as potatoes or
- the nucleotide sequence coding for a thermostable cyanophycin synthetase according to the invention is transferred into one of the host systems mentioned above by known methods. Examples of methods for DNA transfer into suitable host systems are transformation, electroporation, conjugation and agrobacterium-mediated DNA transfer or “particle bombardment”. These lists are only used to explain the present invention and are not limiting.
- a transformed single or multicellular organism resulting from a successfully carried out nuclear acid transfer thus differs from the correspondingly not transformed organism in that it contains additional nucleic acids of the type according to the invention and can accordingly express them.
- the present invention thus also relates to a transformed single or multicellular organism containing a cyanophycin synthetase according to the invention and / or a vector containing a cyanophycin synthetase of the type described above.
- the present invention relates to a method for providing a cyanophycin synthetase according to the invention of the type described above, wherein the nucleotide sequence coding for the enzyme is isolated from a thermophilic single or multicellular organism, if necessary operatively linked to regulatory structures and / or into one suitable for heterologous expression Vector is cloned, optionally transferred to a heterologous host system, expressed there and then isolated from this host system and optionally purified and / or enriched.
- cyanophycin synthetase it is also conceivable to directly isolate an amount of cyanophycin synthetase sufficient for the synthesis of cyanophycm from a thermophilic organism. mus, without the previous enrichment in a heterologous system. Furthermore, the enzyme cyanophycin synthetase according to the invention can then be used, for example, in an in vitro system for the synthesis of cyanophycin and / or its secondary products.
- the present invention also relates to a process for the preparation of cyanophycin and / or its secondary products, a cyanophycin synthetase and / or a vector and / or a transformed single or multicellular organism of the type described above being used.
- the present invention comprises not only the production of cyanophycin and / or its secondary products in a living host system, but also the in vitro synthesis of cyanophycin with the aid of an isolated cyanophycin synthetase of the type described above.
- the process according to the invention for the production of cyanophycin is characterized in that the enzyme-catalyzed synthesis takes place in a temperature range from 35 ° C. to 55 ° C., preferably in a range from 35 ° C. to 50 ° C.
- the process according to the invention is advantageously characterized in that the process is less susceptible to faults due to the wide temperature range, in particular above 28 ° C., allows greater variability in the process control and thus delivers an improved product yield.
- the production of cyanophycin and / or its secondary products according to the invention is thus substantially more reproducible and more economical than the previously known processes.
- the cyanophycin synthetase according to the invention catalyzes an ATP-dependent chain extension reaction (elongation). Surprisingly, the enzyme has two active (catalytic) centers.
- the cyanophycin synthetase according to the invention gradually and alternately (sequentially) incorporates a molecule of aspartic acid and then a molecule of arginine into a cyanophyne precursor (peptide primer). Without a primer, the enzyme-catalyzed
- the present invention further relates to the use of a vector containing a cyanophycin synthetase according to the invention of the aforementioned type for position of a transformed single or multicellular organism as described above.
- a transformed single or multi-cell organism for the production of a cyanophycin synthetase according to the invention and / or for the production of cyanophycin and / or its secondary products is also included in the present invention.
- a cyanophycin synthetase isolated according to the invention can also be used for the in vitro production of cyanophycin and / or its secondary products.
- the use of cyanophycin and / or its derivatives for the production of food supplements and / or agents in the field of agriculture and / or crop protection is covered in the present invention.
- cyanophycin and / or its secondary products can be seen in the paper, textile, pigment, lacquer, ceramic, building material or detergent industries as well as in the areas of water and waste water treatment.
- SDS-PAGE SDS-polyacrylamide gel electrophoresis
- the peptide primers are linked by the following reaction: (i) coupling of Fmoc-Asp-OtBu and subsequently (ii) twice attaching the building block Fmoc-Asp- [Arg- (Pmc) -OtBu] -OH. Furthermore, the N-terminally blocked peptide primer ⁇ -Ahx 2 - (b-Asp-Arg) 3 was produced by attaching Fmoc- ⁇ -aminohexanoic acid (Novabiochem) twice to the peptide primer bound to the resin described above. The finished peptides were made by
- the peptide primer ( ⁇ -Asp-Arg) 3 -Asp was synthesized on a TentaGel-S-PHB resin (Rapp polymers) loaded with Fmoc-Asp (OtBu) by attaching the corresponding building block three times.
- the peptide was also cleaved from the resin and deprotected as previously described. Here, the peptide was obtained as a free acid.
- All peptide primers were purified on a C-18 column (Vydac 201SP54) and analyzed using RP-HPLC and MALDI-MS.
- the dipeptide ⁇ -Asp-Arg was also produced on a TentaGel-S-PHB phase, which had previously been loaded with Fmoc-Arg (Pmc).
- Fmoc-Arg Pmc
- the resin was treated with 4 eq (equivalents) of Boc-Asp-OtBu (Bachern Chemicals), 4 eq O- (benzotriazol-l-yl) - N , N, N ', N'-tetramethyluronium tetrafluoroborate and 8 eq diisopropyl-emylamine treated in DMF.
- the peptide was cleaved from the resin with trifluoroacetic acid containing 1% phenol, 2% water and 3% triisobutylsilane, then precipitated with cold t-butylmethyl and finally purified on a C-18 column (Vydac 201SP54) and with RP-HPLC and MALDI-MS analyzed.
- the reaction batches for product analysis by mass spectrometry contain the following components in a volume of 125 ⁇ l: 100 mM NEUHCO; ⁇ (pH 8.0), 4 mM ATP disodium salt, 20 mM MgCl 2 , 8 mM KC1, 2 mM DTT, 0.2 mM L-aspartic acid, 0.2 mM L-arginine, ⁇ 10 ⁇ M synthetic primers and 3 ⁇ g cyanophycin synthetase.
- the reaction mixture of 125 ⁇ l contains the following: 50 mM Tris-HCl (pH 8.0), 4 mM ATP disodium salt, 20 mM MgCl 2 , 20 mM KC1, 1 mM DTT, 0.8 mM L Aspartic acid, 0.4 mM L-arginine,> 10 ⁇ M synthetic primer and 3 ⁇ g cyanophycin synthetase.
- Various primers (Fig. 1) are added to the reaction mixture. After incubation of the reaction batches for 24 hours at room temperature
- Lane 5 like lane 4 but with about 160 ⁇ M primer. " The diffuse bands below 29 kDa in lanes 1, 2 and 3 represent cyanophycin-like material.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001277555A AU2001277555A1 (en) | 2000-08-09 | 2001-07-27 | Method for improved production of cyanophycin and the secondary products thereof |
EP01955376A EP1309694A2 (de) | 2000-08-09 | 2001-07-27 | Verfahren zur verbesserten herstellung von cyanophycin und dessen folgeprodukte |
US09/923,563 US20020115141A1 (en) | 2000-08-09 | 2001-08-07 | Method for improved production of cyanophycin and secondary products thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10038775 | 2000-08-09 | ||
DE10038775.6 | 2000-08-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002012459A2 true WO2002012459A2 (de) | 2002-02-14 |
WO2002012459A3 WO2002012459A3 (de) | 2002-06-20 |
Family
ID=7651791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/008690 WO2002012459A2 (de) | 2000-08-09 | 2001-07-27 | Verfahren zur verbesserten herstellung von cyanophycin und dessen folgeprodukte |
Country Status (4)
Country | Link |
---|---|
US (1) | US20020115141A1 (de) |
EP (1) | EP1309694A2 (de) |
AU (1) | AU2001277555A1 (de) |
WO (1) | WO2002012459A2 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2167638A4 (de) | 2007-06-27 | 2010-08-11 | Univ Arizona | Reagenzien und verfahren für die cyanobakterielle herstellung von biokunststoffen und biomaterialien |
JP2009171908A (ja) * | 2008-01-26 | 2009-08-06 | Univ Waseda | シアノフィシンの製造方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19709024A1 (de) * | 1997-03-06 | 1998-09-10 | Bayer Ag | Polyasparaginsäure Homo- und Copolymere, ihre biotechnologische Herstellung und Verwendung |
DE19813692A1 (de) * | 1998-03-27 | 1999-09-30 | Norddeutsche Pflanzenzucht Han | Cyanophycinsynthetasegene zur Erzeugung von Cyanophycin oder Cyanophycinderivaten, und ihre Verwendung |
DE19825509A1 (de) * | 1998-06-02 | 1999-12-09 | Bayer Ag | Biotechnische Herstellung von Polyasparaginsäure und deren Modifikation |
-
2001
- 2001-07-27 AU AU2001277555A patent/AU2001277555A1/en not_active Abandoned
- 2001-07-27 WO PCT/EP2001/008690 patent/WO2002012459A2/de not_active Application Discontinuation
- 2001-07-27 EP EP01955376A patent/EP1309694A2/de not_active Withdrawn
- 2001-08-07 US US09/923,563 patent/US20020115141A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19709024A1 (de) * | 1997-03-06 | 1998-09-10 | Bayer Ag | Polyasparaginsäure Homo- und Copolymere, ihre biotechnologische Herstellung und Verwendung |
DE19813692A1 (de) * | 1998-03-27 | 1999-09-30 | Norddeutsche Pflanzenzucht Han | Cyanophycinsynthetasegene zur Erzeugung von Cyanophycin oder Cyanophycinderivaten, und ihre Verwendung |
DE19825509A1 (de) * | 1998-06-02 | 1999-12-09 | Bayer Ag | Biotechnische Herstellung von Polyasparaginsäure und deren Modifikation |
Non-Patent Citations (5)
Title |
---|
BERG HOLGER ET AL: "Biosynthesis of the cyanobacterial reserve polymer multi-L-arginyl-poly-L-aspartic acid (cyanophycin): Mechanism of the cyanophycin synthetase reaction studied with synthetic primers." EUROPEAN JOURNAL OF BIOCHEMISTRY, Bd. 267, Nr. 17, September 2000 (2000-09), Seiten 5561-5570, XP002182772 ISSN: 0014-2956 * |
HAI TRAN ET AL: "Purification and characterization of cyanophycin and cyanophycin synthetase from the thermophilic Synechococcus sp. MA19." FEMS MICROBIOLOGY LETTERS, Bd. 181, Nr. 2, 15. Dezember 1999 (1999-12-15), Seiten 229-236, XP001031441 ISSN: 0378-1097 in der Anmeldung erw{hnt * |
MUEHLENHOFF ULRICH: "The FAPY-DNA glycosylase (Fpg) is required for survival of the cyanobacterium Synechococcus elongatus under high light irradiance." FEMS MICROBIOLOGY LETTERS, Bd. 187, Nr. 2, 2000, Seiten 127-132, XP001031459 ISSN: 0378-1097 * |
SCHNEIDER DIRK ET AL: "Sequence of the two operons encoding the four core subunits of the cytochrome b6f complex from the thermophilic cyanobacterium Synechococcus elongatus." BIOCHIMICA ET BIOPHYSICA ACTA, Bd. 1491, Nr. 1-3, 25. April 2000 (2000-04-25), Seiten 364-368, XP001031458 ISSN: 0006-3002 * |
ZIEGLER KARL ET AL: "Molecular characterization of cyanophycin synthetase, the enzyme catalyzing the biosynthesis of the cyanobacterial reserve material multi-L-arginyl-poly-L-aspartate (cyanophycin)." EUROPEAN JOURNAL OF BIOCHEMISTRY, Bd. 254, Nr. 1, Mai 1998 (1998-05), Seiten 154-159, XP002182773 ISSN: 0014-2956 * |
Also Published As
Publication number | Publication date |
---|---|
AU2001277555A1 (en) | 2002-02-18 |
WO2002012459A3 (de) | 2002-06-20 |
US20020115141A1 (en) | 2002-08-22 |
EP1309694A2 (de) | 2003-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69131834T2 (de) | Serinproteasevarianten mit peptidligase aktivität | |
DE19605657B4 (de) | Menschliches Proinsulinderivat, Kodierende DNA, DNA enthaltender Expressionsvektor, mit diesem transformierter Mikroorganismus und Verwendung dieses menschlichen Proinsulinderivats | |
DE60208343T2 (de) | FUSIONSPROTEINE aus hirudin und proinsulin oder insulin | |
WO2006076902A2 (de) | Rekombinante expression von proteinen in einer disulfidverbrückten, zweikettigen form | |
DE69535696T2 (de) | Tripeptidyl-aminopeptidase | |
DE2822568A1 (de) | Dns-transfer-vektor und ein gen eines hoeheren organismus enthaltender mikroorganismus | |
Pierre et al. | Identification and analysis of venom gland-specific genes from the coastal taipan (Oxyuranus scutellatus) and related species | |
DE60115863T2 (de) | Beta 1, 2-xylosyltransferase gen aus arabidopsis | |
DE3931716C2 (de) | Rekombinante DNA, eine sie enthaltende Transformante und ein Verfahren zur Herstellung von wärmestabiler Glucosedehydrogenase und ihre Verwendung | |
DE69118946T2 (de) | Thermostabile Mutanten von neutraler Protease und Vorkehrungen zu deren Herstellung | |
DE69531301T2 (de) | Dna kodierend für die bacillus licheniformis pwd-1 keratinase | |
DE69318495T2 (de) | Verfahren zur Reinigung des Big-Endothelin Proteins | |
WO2002012459A2 (de) | Verfahren zur verbesserten herstellung von cyanophycin und dessen folgeprodukte | |
DE69331742T2 (de) | Neuartige protease | |
DE3586926T2 (de) | Schweinepankreas-elastase. | |
DE69936363T2 (de) | DNAs die für neue fusions-Proteine kodieren und Verfahren zur Herstellung von nützlichen Polypeptiden durch Expression der DNAs | |
DE60125386T2 (de) | Verfahren zur Prävention einer durch Gefrieren induzierten Abnahme der Aktivität eines Proteins | |
EP1244776A2 (de) | Tetrahydropyrimidin-dioxygenase-gen, dadurch kodierte polypeptide und verfahren zur deren herstellung | |
DE69434246T2 (de) | Ectoin - synthetasegen | |
DE69729780T2 (de) | Protein mit Ethylendiamine-N,N'-Dibarnsteinsäure: Ethylendiamin Lyase Aktivität und dafür kodierendes Gen | |
DE69827486T2 (de) | Aminopeptidase, welche von bacillus licheniformis abstammt und verfahren zur herstellung von proteinen des natürlichen typs | |
EP1169461A2 (de) | Herstellung von pankreatischer procarboxypeptidase b, isoformen und muteinen davon und ihre verwendung | |
AU708689B2 (en) | Polynucleotides and the proteins encoded thereby, suitable for controlling lamellicorn beetles | |
DE69023655T2 (de) | Verfahren zur Isolierung und Expression eines für Streptokinase kodierenden Gens, Nukleotidsequenz, rekombinante DNA und transformierter Mikroorganismus. | |
DE102004055686A1 (de) | Modifizierte Sarcosinoxidasen, modifizierte Sarcosinoxidasegene und Verfahren zur Herstellung von modifizierten Sarcosinoxidasen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 09923563 Country of ref document: US |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001955376 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001955376 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001955376 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |